The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans. (Q40476551)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans. |
scientific article |
Statements
The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans (English)
Ronald J Ozminkowski
Kevin Hawkins
Shaohung Wang
Sarah C Stallings
Stan N Finkelstein
Anthony J Sinskey